mafenide has been researched along with Gastritis in 1 studies
Mafenide: A sulfonamide that inhibits the enzyme CARBONIC ANHYDRASE and is used as a topical anti-bacterial agent, especially in burn therapy.
Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishimori, I | 1 |
| Minakuchi, T | 1 |
| Morimoto, K | 1 |
| Sano, S | 1 |
| Onishi, S | 1 |
| Takeuchi, H | 1 |
| Vullo, D | 1 |
| Scozzafava, A | 1 |
| Supuran, CT | 1 |
1 other study available for mafenide and Gastritis
| Article | Year |
|---|---|
Carbonic anhydrase inhibitors: DNA cloning and inhibition studies of the alpha-carbonic anhydrase from Helicobacter pylori, a new target for developing sulfonamide and sulfamate gastric drugs.
Topics: Amino Acid Sequence; Carbonic Anhydrase Inhibitors; Carbonic Anhydrases; Cloning, Molecular; DNA, Ba | 2006 |